| Innate immunity mediated by TLR9 modulates pathogenicity in an animal model of multiple sclerosis M Prinz, F Garbe, H Schmidt, A Mildner, I Gutcher, K Wolter, M Piesche, ... The Journal of clinical investigation 116 (2), 456-464, 2006 | 479 | 2006 |
| Identification of microRNAs in the cerebrospinal fluid as marker for primary diffuse large B-cell lymphoma of the central nervous system A Baraniskin, J Kuhnhenn, U Schlegel, A Chan, M Deckert, R Gold, ... Blood, The Journal of the American Society of Hematology 117 (11), 3140-3146, 2011 | 369 | 2011 |
| Combined analysis of ZAP-70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukemia R Schroers, F Griesinger, L Trümper, D Haase, B Kulle, L Klein-Hitpass, ... Leukemia 19 (5), 750-758, 2005 | 312 | 2005 |
| Midostaurin added to chemotherapy and continued single-agent maintenance therapy in acute myeloid leukemia with FLT3-ITD RF Schlenk, D Weber, W Fiedler, HR Salih, G Wulf, H Salwender, ... Blood, The Journal of the American Society of Hematology 133 (8), 840-851, 2019 | 297 | 2019 |
| Identification of microRNAs in the cerebrospinal fluid as biomarker for the diagnosis of glioma A Baraniskin, J Kuhnhenn, U Schlegel, A Maghnouj, H Zöllner, ... Neuro-oncology 14 (1), 29-33, 2012 | 225 | 2012 |
| GLA/DRST real-world outcome analysis of CAR T-cell therapies for large B-cell lymphoma in Germany WA Bethge, P Martus, M Schmitt, U Holtick, M Subklewe, B von Tresckow, ... Blood, The Journal of the American Society of Hematology 140 (4), 349-358, 2022 | 174 | 2022 |
| Circulating U2 small nuclear RNA fragments as a novel diagnostic biomarker for pancreatic and colorectal adenocarcinoma A Baraniskin, S Nöpel‐Dünnebacke, M Ahrens, SG Jensen, H Zöllner, ... International journal of cancer 132 (2), E48-E57, 2013 | 172 | 2013 |
| Transduction of human PBMC-derived dendritic cells and macrophages by an HIV-1-based lentiviral vector system R Schroers, I Sinha, H Segall, IGH Schmidt-Wolf, CM Rooney, ... Molecular Therapy 1 (2), 171-179, 2000 | 152 | 2000 |
| Phase II study of central nervous system (CNS)-directed chemotherapy including high-dose chemotherapy with autologous stem cell transplantation for CNS relapse of aggressive … A Korfel, T Elter, E Thiel, M Hänel, R Möhle, R Schroers, M Reiser, ... haematologica 98 (3), 364, 2013 | 150 | 2013 |
| Identification of HLA DR7-restricted epitopes from human telomerase reverse transcriptase recognized by CD4+ T-helper cells R Schroers, XF Huang, J Hammer, J Zhang, SY Chen Cancer research 62 (9), 2600-2605, 2002 | 135 | 2002 |
| Hemophagocytic lymphohistiocytosis in adults: collaborative analysis of 137 cases of a nationwide German registry S Birndt, T Schenk, B Heinevetter, FM Brunkhorst, G Maschmeyer, ... Journal of cancer research and clinical oncology 146, 1065-1077, 2020 | 123 | 2020 |
| Current strategies in the diagnosis of diffuse large B‐cell lymphoma of the central nervous system A Baraniskin, M Deckert, G Schulte‐Altedorneburg, U Schlegel, ... British journal of haematology 156 (4), 421-432, 2012 | 112 | 2012 |
| Measurable residual disease monitoring in acute myeloid leukemia with t (8; 21)(q22; q22. 1): results from the AML Study Group FG Rücker, M Agrawal, A Corbacioglu, D Weber, S Kapp-Schwoerer, ... Blood, The Journal of the American Society of Hematology 134 (19), 1608-1618, 2019 | 106 | 2019 |
| Human telomerase reverse transcriptase-specific T-helper responses induced by promiscuous major histocompatibility complex class II-restricted epitopes R Schroers, L Shen, L Rollins, CM Rooney, K Slawin, G Sonderstrup, ... Clinical cancer research 9 (13), 4743-4755, 2003 | 101 | 2003 |
| MicroRNAs in cerebrospinal fluid as biomarker for disease course monitoring in primary central nervous system lymphoma A Baraniskin, J Kuhnhenn, U Schlegel, W Schmiegel, S Hahn, R Schroers Journal of neuro-oncology 109, 239-244, 2012 | 94 | 2012 |
| Diagnosis of leptomeningeal disease in diffuse large B‐cell lymphomas of the central nervous system by flow cytometry and cytopathology R Schroers, A Baraniskin, C Heute, M Vorgerd, A Brunn, J Kuhnhenn, ... European journal of haematology 85 (6), 520-528, 2010 | 93 | 2010 |
| High-dose chemotherapy with autologous haematopoietic stem cell support for relapsed or refractory primary CNS lymphoma: a prospective multicentre trial by the German … B Kasenda, G Ihorst, R Schroers, A Korfel, I Schmidt-Wolf, G Egerer, ... Leukemia 31 (12), 2623-2629, 2017 | 90 | 2017 |
| Autologous stem cell transplantation for progressive systemic sclerosis: a prospective non-interventional study from the European Society for Blood and Marrow Transplantation … J Henes, MC Oliveira, M Labopin, M Badoglio, HU Scherer, N Del Papa, ... haematologica 106 (2), 375, 2021 | 88 | 2021 |
| Systematic screening for mutations in the 5′‐regulatory region of the human dopamine D1 receptor (DRD1) gene in patients with schizophrenia and bipolar … S Cichon, MM Nöthen, G Stöber, R Schroers, M Albus, W Maier, ... American journal of medical genetics 67 (4), 424-428, 1996 | 85 | 1996 |
| Gene transfer into human T lymphocytes and natural killer cells by Ad5/F35 chimeric adenoviral vectors R Schroers, Y Hildebrandt, J Hasenkamp, B Glass, A Lieber, G Wulf, ... Experimental hematology 32 (6), 536-546, 2004 | 78 | 2004 |
